Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey

↑ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 70 days • 1 price levels

Days at Price

Price Analysis

Most common price: £495 (70 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 70 days

Description

This econometric study covers the latent demand outlook for inflammatory bowel disease therapeutics across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 5,000 cities in India. For each city in question, the percent share the city is of it's state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-a-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state or union territory and city, latent demand estimates are created for inflammatory bowel disease therapeutics. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the cities in India). This study gives, however, my estimates for the latent demand, or the P.I.E., for inflammatory bowel disease therapeutics in India. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of India. For each state or union territory, I also show my estimates of how the P.I.E. grows over time. In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on strategic planning at graduate schools of business.

Product Specifications

Format: paperback
ASIN: B00E198WVU
Category: Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain: Amazon UK
Release Date: 19 June 2013
Listed Since: 23 July 2013

It has never been this cheap. We have no record of a lower price.

The 2013-2018 Outlook for Inflammatory Bowel Disease Therapeutics in India

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

Inflammatory Bowel Disease: Pathogenesis, Diagnosis and Management (Clinical Gastroenterology)

Inflammatory Bowel Disease: Diagnosis and Treatment

Biological Therapy for Inflammatory Bowel Disease

Inflammatory Bowel Disease: A Clinician's Guide

CBT for Patients with Inflammatory Bowel Disease: A Treatment Manual

Inflammatory Bowel Disease

New Insights into Inflammatory Bowel Disease

Atlas of Surgical Treatment of Inflammatory Bowel Disease

The 2023-2028 Outlook for Ulcerative Proctitis in the United States

Inflammatory Bowel Disease and Irritable Bowel Syndrome

Ulcerative Colitis - Treatments, Special Populations and the Future

Pediatric Inflammatory Bowel Disease

Chronisch-entzündliche Darmerkrankungen: in Klinik und Praxis

Ulcerative Colitis from Genetics to Complications

Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy

Gastrointestinal Inflammations and Gut Microbiota: Pathophysiology, Management, and Emerging Therapies

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States

Inflammatory Bowel Diseases: New Developments and Standards: 82 (Falk Symposium, 82)

It has never been this cheap. We have no record of a lower price.

The 2013-2018 Outlook for Inflammatory Bowel Disease Therapeutics in India

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

Inflammatory Bowel Disease: Pathogenesis, Diagnosis and Management (Clinical Gastroenterology)

Inflammatory Bowel Disease: Diagnosis and Treatment

Biological Therapy for Inflammatory Bowel Disease

Inflammatory Bowel Disease: A Clinician's Guide

CBT for Patients with Inflammatory Bowel Disease: A Treatment Manual

Inflammatory Bowel Disease

New Insights into Inflammatory Bowel Disease

Atlas of Surgical Treatment of Inflammatory Bowel Disease

The 2023-2028 Outlook for Ulcerative Proctitis in the United States

Inflammatory Bowel Disease and Irritable Bowel Syndrome

Ulcerative Colitis - Treatments, Special Populations and the Future

Pediatric Inflammatory Bowel Disease

Chronisch-entzündliche Darmerkrankungen: in Klinik und Praxis

Ulcerative Colitis from Genetics to Complications

Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy

Gastrointestinal Inflammations and Gut Microbiota: Pathophysiology, Management, and Emerging Therapies

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States

Inflammatory Bowel Diseases: New Developments and Standards: 82 (Falk Symposium, 82)